NASDAQInformation TechnologySolarSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Expand EPC project portfolio revenue | The company aims to expand this portfolio to drive more sales. | Intact | annual revenue falls below $60M in FY26 | Revenue: $10.244M FY2026-Q2; GAAP. Published target: >= $90M annual revenue by FY26. Target period is not explicitly aligned with this observation. Source published Oct 8, 202610,243,612 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: e1896cb6-3311-4cb8-91d8-bc41874691d8. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 3 quarters including 2026-Q1 and 2026-Q2. Fiscal 2025 revenue grew nearly 300% year-over-year to $91.0 million, and 2026-Q2 revenue increased 49% year-over-year to $10.2 million. Management consistently emphasizes EPC portfolio expansion, and the revenue growth trajectory aligns with this focus, indicating delivering progress. Delivery assessment Oct 24, 2026 |
Stabilize management and governance | A supporting condition in SolarMax Technology Inc's published investment case. The stated target is No further key management departures in next 4 quarters. | Intact | Additional key management departures occur within next 4 quarters | 0 key departures vs 0 allowed News feed empty for management changes. Events show delisting notice and rights modifications, but no executive departures. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Regain Nasdaq listing compliance | If it regains Nasdaq compliance, it can stabilize its market presence. | Under Pressure | Failure to regain Nasdaq compliance by end of 2026 | Compliance deadline 2026-12-31 vs current date 2026-10-24 Nasdaq notice of delisting received Aug 2026 for failure to file 10-Q. No subsequent compliance confirmation in evidence. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 disclosures in 2026-Q2. Management executed a 1-for-12 reverse stock split in August 2026 to support regaining Nasdaq minimum bid price compliance by August 31, 2026. The company also received notices for failure to file Form 10-Q and market value compliance. The trajectory shows active regulatory response but compliance remains pending, indicating limited progress. Delivery assessment Oct 24, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 13, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk growth story tied to expanding its EPC project portfolio, not a proven compounder, as the company remains loss-making. The multi-year view is in a watch state: management shows progress on growth and gross profit, while recent momentum has weakened sharply.
The available valuation signal says SMXT is cheap versus peers, but confidence in that comparison is low and the business is loss-making. The evidence does not specify what earnings or growth expectations the market assumes, so the expectations gap is unclear.
Near-term results show rapid revenue growth, including fiscal 2025 revenue growth of nearly 300% and 49% year-over-year growth in 2026-Q2; gross profit also rose year over year. Yet recent financial performance remains weak relative to its industry cohort, momentum fell sharply, and management faces unresolved Nasdaq compliance issues. A guidance cut on the next call is a stated downside risk.
Over the next several quarters, the thesis depends on whether EPC expansion and project completion continue to lift revenue and gross profit without a guidance cut. Nasdaq compliance remains a key company-specific swing factor. Fed rate cuts and stronger results or guidance from sector peers could support the backdrop, but do not resolve SMXT’s execution risks.
For the 1-to-3-year view, SMXT has visible growth and gross-profit progress, but losses, weak relative performance, volatile management, and compliance concerns leave the thesis uncertain. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.